Orforglipron vs Mounjaro vs Wegovy
Now that the UAE is set to introduce the first GLP-1 weight loss pill, let’s compare the three leading options side by side.
With Orforglipron expected to launch in May 2026, patients now have a non-injectable alternative to established treatments like Mounjaro and Wegovy.
But how do they actually compare in terms of:
- Weight loss results
- Convenience
- Effectiveness
- Suitability
This guide breaks it down clearly — so you can understand which option is right for you.
What Are the Three Options?
Mounjaro (Tirzepatide)
- Weekly injection
- Dual hormone action (GLP-1 + GIP)
- Highest weight loss results available
Wegovy (Semaglutide)
- Weekly injection
- GLP-1 only
- Proven, globally established treatment
Orforglipron (New Tablet – UAE 2026)
- Daily tablet (no injections)
- GLP-1 only
- Developed by Eli Lilly
- First oral GLP-1 option for weight loss
Unlike Mounjaro, it does not activate GIP.
What Are GLP-1 and GIP?
Before comparing the medications, it helps to understand how they actually work — in simple terms.
What is GLP-1?
GLP-1 is a natural hormone your body already produces after you eat.
Think of it as your body’s “I’m full” signal.
It helps with weight loss by:
- Reducing your appetite
- Making you feel full faster
- Slowing down how quickly food leaves your stomach
- Reducing cravings (especially for sugary foods)
In simple terms:
GLP-1 helps you eat less without constantly feeling hungry.
What is GIP?
GIP is another natural hormone involved in how your body processes food.
It works alongside GLP-1, but adds an extra effect:
- Improves how your body uses energy
- Helps regulate blood sugar more efficiently
- Enhances fat metabolism
In simple terms:
GIP helps your body use calories more efficiently and burn fat more effectively.
Why This Matters for Weight Loss
- Wegovy & Orforglipron → work on GLP-1 only
- Mounjaro → works on GLP-1 + GIP (dual action)
That’s why Mounjaro typically leads to greater weight loss results.
Simple Analogy
- GLP-1 = “Eat less”
- GIP = “Use energy better”
Mounjaro does both — which is why it’s stronger.
Side-by-Side Comparison
Which is most effective?
Mounjaro
- Up to 22.5% weight loss over 72 weeks
- Strongest clinical results
- Best for higher BMI / aggressive weight loss goals
Wegovy
- Around 12–15% average weight loss
- Reliable and widely used
- Good balance of effectiveness and tolerability
Orforglipron
- Up to 12.4% weight loss in trials
- First effective tablet alternative
- Ideal for patients avoiding injections
Tablet vs Injections – What really matters?
This is where the real decision happens.
Injections (Mounjaro & Wegovy)
- Stronger results
- Less frequent dosing (weekly)
- Clinically proven long-term
Tablet (Orforglipron)
- No needles
- Daily routine
- Easier for many patients to start
Reality:
Most patients choose based on comfort + lifestyle, not just results.
Side Effects
All three medications have similar side effects:
- Nausea
- Digestive discomfort
- Reduced appetite
- Fatigue (sometimes)
These usually:
- Occur early
- Improve with dose adjustment
UAE Availability
- Mounjaro → Available now
- Wegovy → Available now
- Orforglipron → Expected May 2026 (UAE)
This is why demand is already building — and why you’re seeing it in the news.
Which one should you choose?
Be honest — it depends on your goal and your medical history.
Choose Mounjaro:
- Maximum weight loss
- Faster results
- Higher BMI
Choose Wegovy:
- Proven option
- Balanced approach
Choose Orforglipron:
- You don’t want injections
- Prefer convenience
- Earlier-stage weight loss
The medication is just one part.
At Allure Weightloss, we focus on:
- Medical screening
- Ongoing monitoring
- Dietitian-led support
- Long-term weight management
That’s what actually determines success.
Thinking about weight loss medication in Dubai?
Message our team to:
- Check eligibility
- Compare options
- Get a personalised plan
Learn more about our medically supervised weight loss programmes
